Home Recalls D-1341-2019
Class II · Moderate risk Terminated Initiated May 31, 2019 (7 years ago)
ZYFLO CR (zileuton) extended-release tablets, 600 mg, 120-count bottles, Rx only…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Failed Dissolution Specifications: Out of specification result for dissolution.
What was recalled
ZYFLO CR (zileuton) extended-release tablets, 600 mg, 120-count bottles, Rx only, Distributed by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-902-12.
Recalling firm Chiesi USA, Inc.
NDC code 10122-902-12
Origin NC, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-1341-2019
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Terminated Jun 10, 2022
Reason Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.
Class II · Moderate risk Terminated May 31, 2019
Reason Failed Dissolution Specifications: Out of specification result for dissolution.